Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Efficient transfection method for primary cells.

Astrid Hamm1, Nicole Krott, Ines Breibach

  • 1Institute of Pathology, RWTH, Aachen, Germany.

Tissue Engineering
|May 29, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deciphering melanoma brain metastases: Role of cellular plasticity and metastatic origin.

Biomaterials advances·2026
Same author

Biofabrication of 3D-printed, pre-cross-linked alginate dialdehyde-gelatin (ADA-GEL) scaffolds for an <i>in vivo</i> metastatic arteriovenous loop tumor model.

Frontiers in bioengineering and biotechnology·2025
Same author

The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

[Pulmonary Hypertension Associated with Left Heart Disease].

Pneumologie (Stuttgart, Germany)·2025
Same author

Modeling a mesenchymal cell state by bioprinting for the molecular analysis of dormancy in melanoma.

Materials today. Bio·2025
Same author

Alginate-Dialdehyde-Based Reporter Ink Enabling Online Detection of Matrix Metalloproteinase Activity of Encapsulated Cells.

ACS biomaterials science & engineering·2025

Transfecting primary cells and stem cells is challenging. Nucleofector technology offers high-efficiency transfection for these cell types, overcoming limitations of traditional methods.

Area of Science:

  • Cell biology
  • Molecular biology
  • Biotechnology

Background:

  • Transfection of primary cells and stem cells is a significant challenge in laboratory settings, impacting tissue engineering and gene therapy.
  • Conventional transfection methods effective for cell lines often yield poor results with primary cells.

Purpose of the Study:

  • To evaluate the efficacy of Nucleofector technology for transfecting various primary human cells and stem cells.
  • To compare Nucleofector technology with liposome-mediated transfection for these challenging cell types.

Main Methods:

  • Utilized Nucleofector technology (amaxa biosystems) for transfection.
  • Tested on primary human melanocytes, human coronary smooth muscle cells, human chondrocytes, and human mesenchymal stem cells.
  • Compared results with liposome-mediated transfection methods.

Related Experiment Videos

Main Results:

  • Achieved high transfection efficiencies (28.9-45.3%) in primary human melanocytes, coronary smooth muscle cells, chondrocytes, and mesenchymal stem cells.
  • Liposome-mediated transfection proved unsatisfactory for all tested primary cell types.
  • Cell viability post-transfection varied (11.2%-75%) compared to untreated controls.
  • Required only 200,000 cells per transfection sample.

Conclusions:

  • Nucleofector technology provides an effective and rapid method for transfecting primary and stem cells.
  • This technology overcomes the low transfection efficiencies often encountered with other methods in these cell types.
  • Demonstrated successful application across four distinct primary cell types.